Search

everythinglearnresearchcommunity

for

Search:↓

A woman with lupus improved significantly from scalp hair loss after treatment, highlighting the need to identify psoriatic alopecia in lupus patients to avoid permanent hair loss.

A patient developed a blister at the injection site after hepatitis C treatment.

SM04554 may increase hair growth as a topical treatment for androgenetic alopecia.

Contact immunotherapy might help treat various skin conditions, but more research is needed to confirm its safety and effectiveness.

Using combined treatments can help manage acne by targeting the bacteria and skin changes that cause it.

10.5% of sheep in Ismailia, Egypt, had Sarcoptes scabiei, causing skin issues.

A man had both alopecia areata and lichen planus, which is uncommon.

Red blood cell folate levels are reliable indicators of long-term folate status in alopecia areata patients.

SB414 may be an effective treatment for atopic dermatitis by reducing swelling and bacterial infection.

Common noncancerous skin diseases have various treatments, including topical applications, light therapy, surgery, and medications, with psychological support being important.

The document concludes that doctors should recognize congenital triangular alopecia to avoid unnecessary treatments, as it does not respond to steroids like alopecia areata does.

The exam tested knowledge on various skin-related topics for CME credit.

The article suggests managing interferon beta therapy side effects in MS with dose adjustments, medications, and patient education.

Skin grafts on mice can cause an immune response leading to hair loss, useful for studying human hair loss conditions.

CCCA is a scarring hair loss condition mainly in African descent women, possibly caused by genetics and hairstyling, treated with gentle hair care and medications.

Early onset and pustules indicate severe hair follicle inflammation, and while antibiotics help, the condition often worsens after treatment stops.

The document concludes that while there are various treatments for Alopecia Areata, there is no cure, and individualized treatment plans are essential due to varying effectiveness.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Chemotherapy can cause hair changes similar to alopecia areata, which might lead to misdiagnosis.

Immune cells help regulate hair growth, and better understanding this can improve hair loss treatments.

Hair loss is a rare but recognized symptom of pemphigus vulgaris, with patients usually regrowing hair after treatment.

Nested PCR can reliably identify fungal infections when traditional methods fail.

A mother and son both had ulcerative colitis and alopecia, suggesting a genetic link in autoimmune disorders and successful treatment with cyclosporine.

The conclusion is that primary scarring alopecia is a complex condition that requires early and accurate diagnosis for effective treatment.

Early stage bald spots are linked to skin inflammation and damage to the upper part of the hair follicle.

The combination of cyclosporine and PUVA might help treat severe alopecia areata.

Topical tacrolimus did not regrow hair in alopecia universalis patients.

Managing frontal fibrosing alopecia and lichen planus pigmentosus is challenging due to resistant hair loss and skin discoloration.